Focus: Nordic Pharma is a Paris-based private specialty pharmaceutical and diagnostic company focused on metabolic diseases, with primary revenue concentration in hyaluronic acid and methotrexate products. The company operates at a modest scale with only 2 active job openings, indicating a small, focused commercial footprint.
Profile data last refreshed 8h ago · AI intelligence enriched 3w ago
Nordic Pharma may suit niche specialists seeking focused diagnostic/metabolic disease work in a private setting, but the severe revenue concentration, minimal hiring, and lack of financial transparency present material career risk.
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Core revenue driver (100% of company revenue); peak-stage methotrexate NDA with established market presence and stable Part D utilization.
Help build intelligence for Nordic Pharma
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Generated by Claude from Nordic Pharma's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.
Secondary product approaching loss of exclusivity; likely transitional revenue contributor with declining market defensibility.
1 discontinued, 0 duplicate formulations not shown
Based on last 4 crawl cycles
Source: USCIS H-1B Employer Data Hub
Upgrade to Pro to access AI interview prep brief and other premium pharma intelligence.
Upgrade to Pro — $25/mo